RBC
ABBV icon

Ronald Blue & Co’s AbbVie ABBV Stock Holding History

Ronald Blue & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$898K Buy
12,386
+484
+4% +$32.5K 0.03% 83
2017
Q1 		$776K Buy
11,902
+7,535
+173% +$474K 0.03% 88
2016
Q4 		$274K Sell
4,367
-5,413
-55% -$330K 0.01% 156
2016
Q3 		$617K Buy
9,780
+253
+3% +$16.4K 0.03% 94
2016
Q2 		$589K Sell
9,527
-100
-1% -$6.09K 0.03% 98
2016
Q1 		$550K Sell
9,627
-1,927
-17% -$107K 0.03% 89
2015
Q4 		$684K Sell
11,554
-9,103
-44% -$524K 0.04% 77
2015
Q3 		$1.12M Sell
20,657
-2,245
-10% -$146K 0.06% 70
2015
Q2 		$1.54M Buy
22,902
+1,482
+7% +$96.8K 0.07% 51
2015
Q1 		$1.25M Sell
21,420
-3,145
-13% -$190K 0.06% 68
2014
Q4 		$1.61M Sell
24,565
-1,190
-5% -$75K 0.08% 54
2014
Q3 		$1.49M Buy
25,755
+2,182
+9% +$121K 0.1% 50
2014
Q2 		$1.33M Buy
23,573
+3,559
+18% +$187K 0.08% 60
2014
Q1 		$1.03M Buy
20,014
+269
+1% +$13.6K 0.08% 72
2013
Q4 		$1.04M Sell
19,745
-14,211
-42% -$698K 0.08% 74
2013
Q3 		$1.52M Buy
33,956
+6,692
+25% +$297K 0.12% 44
2013
Q2 		$1.13M Buy
+27,264
New +$1.19M 0.09% 39

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ronald Blue & Co's ABBV Position: Q2 2017 in Review

Ronald Blue & Co increased its AbbVie (ABBV) stake by 4.1% in Q2 2017, buying an estimated $32.5K and bringing the position to 12,386 shares worth $898K. The position accounts for 0.03% of the portfolio, ranked #83.

Ronald Blue & Co first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.61M in Q4 2014. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Ronald Blue & Co held 12,386 shares of AbbVie worth $898K as of Q2 2017.
  • Ronald Blue & Co bought 484 AbbVie shares in Q2 2017, an estimated $32.5K.
  • AbbVie made up 0.03% of Ronald Blue & Co's portfolio in Q2 2017, its #83 holding.
  • Ronald Blue & Co first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
  • Ronald Blue & Co's AbbVie position peaked at $1.61M in Q4 2014.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.